. 2016 Dec 28;22(6):290–300. doi: 10.1080/13510002.2016.1273437

Table 4. Effect of galangin on reduced glutathione in the plasma and tissues of normal and STZ-induced diabetic rats.

Groups	Plasma GSH (mg/dl)	Tissue GSH (µg/mg protein)
Groups	Plasma GSH (mg/dl)	Liver	Kidney
Control	28.86 ± 1.78^a	14.25 ± 1.20^a	9.55 ± 0.74^a
Control + galangin (8 mg/kg BW)	33.04 ± 2.85^a	14.92 ± 1.34^a	9.97 ± 1.62^a
Diabetic control	16.65 ± 1.33^b	5.06 ± 0.36^b	4.82 ± 0.30^b
Diabetic + galangin (8 mg/kg BW)	23.98 ± 1.56^c	12.08 ± 1.0^c	8.18 ± 0.60^c
Diabetic + glibenclamide (600 µg/kg BW)	27.42 ± 2.64^a,c	13.64 ± 1.28^a	8.89 ± 0.57^c

Values are given as means ± S.D. from six rats in each group.

^a,b,cValues not sharing a common superscript differ significantly at P < 0.05. DMRT.